What You Should Know:
– Livara Health, a leading provider of value-based musculoskeletal (MSK) management solutions, raises $15M in Series B funding led by A1 Health Ventures.
– Existing investors Polaris Partners, Providence Ventures, Martin Ventures, and a new strategic investor also participated in the round.
Livara Health: A Leader in Value-Based MSK Care
Livara Health (formerly SpineZone) offers a comprehensive value-based MSK management solution. Through a combination of:
- Care Planning: Livara creates individualized care plans for optimal patient outcomes.
- Virtual-First Care: The company prioritizes virtual consultations, increasing accessibility and convenience.
- Care Navigation: Livara provides ongoing support and guidance to patients throughout their care journey.
Livara partners with various healthcare stakeholders, including:
- Providers: Innovative healthcare providers seeking to implement value-based MSK care models.
- Payors: Commercial and Medicare insurance companies seeking cost-effective solutions for MSK care.
- Utilization Management Companies: Organizations focused on optimizing healthcare resource allocation.
- Value-Based Health Systems: Healthcare systems transitioning towards value-based care models.
Milestones to Date
Since its inception, Livara has:
- Treated Over 120,000 Patients: Livara boasts a significant history of successfully managing MSK care for a large patient population.
- Reached Nearly 4 Million People: By 2024, Livara’s MSK management platform has the potential to reach nearly 4 million individuals through partnerships with health plans and providers.
Investing in Innovation for Better Musculoskeletal Care
The new funding will empower Livara Health to:
- Advance Technology and Clinical Capabilities: Livara will leverage the investment to further develop its technology platform and refine its clinical expertise for superior patient outcomes.
- Expand Market Reach: The company plans to reach a wider range of patients and healthcare partners, offering its value-based care model to a larger population.
- Assume Total Cost of Care: Livara aims to expand its risk management capabilities, potentially assuming total cost of care for MSK conditions for its partners.
“At Livara, we are building a better musculoskeletal management solution, taking a biopsychosocial approach to patient care. Having treated patients for over 15 years through both virtual and in-person care pathways, we understand that delivering genuine patient-centered care requires a deep clinical program that can only be built through experience,” said Rob Cohen, Chief Executive Officer of Livara Health. “This new round of funding will help us expand our already proven healthier standard of care for musculoskeletal patients and broaden our proprietary care delivery model focused on ensuring appropriate care pathways for all patients.”
